A 12-year-old Japanese girl with Williams syndrome and osteoporosis presented with very low bone mineral density and received treatment with denosumab.
Based on the most recent available literature, the EULAR updated the points-to-consider on using immunomodulatory therapies in COVID-19, from a rheumatology perspective.
Researchers assessed the immune response of patients with rheumatoid arthritis and seronegative spondyloarthritis to mRNA COVID-19 vaccination after the first and second dose.
Investigators sought to identify oral clinical manifestations due to oral mucosa changes associated with IBD among patients with spondyloarthritis without a diagnosis of IBD.
KEEPSAKE 2 is a clinical trial evaluating the efficacy and safety of risankizumab in patients with psoriatic arthritis.
Researchers evaluated the cellular and transcriptional differences in subsets of cutaneous lupus erythematosus, and studied the association between cutaneous inflammation and systemic disease activity.
Researchers compared the efficacy of romosozumab vs teriparatide in improving vertebral bone structure in women with low bone density.
Researchers studied chronic widespread pain with the 1990 (CWP1990) and 2019 (CWP2019) criteria, a total of 6 years after the onset of rheumatoid arthritis.
An overview of research indicating the association between rheumatic diseases and the liver, and the management of patients with rheumatic disease with liver involvement.
In a meta-analysis, study authors assessed the effectiveness and safety of nonsteroidal anti-inflammatory drugs and opioids for knee and hip osteoarthritis pain and physical function.
